Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Dec;87(12):1230-1; author reply 1232.
doi: 10.1016/j.mayocp.2012.10.005.

Olmesartan and intestinal adverse effects in the ROADMAP study

Jan Menne, Hermann Haller
Comment

Olmesartan and intestinal adverse effects in the ROADMAP study

Jan Menne et al. Mayo Clin Proc. 2012 Dec.
No abstract available

PubMed Disclaimer

Comment on

  • Severe spruelike enteropathy associated with olmesartan.
    Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, Murray JA. Rubio-Tapia A, et al. Mayo Clin Proc. 2012 Aug;87(8):732-8. doi: 10.1016/j.mayocp.2012.06.003. Epub 2012 Jun 22. Mayo Clin Proc. 2012. PMID: 22728033 Free PMC article.

References

    1. Rubio-Tapia A., Herman M.L., Ludvigsson J.F. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012;87(8):732–738. - PMC - PubMed
    1. Haller H., Ito S., Izzo J.L., Jr Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364(10):907–917. - PubMed
    1. Haller H., Viberti G.C., Mimran A. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. J Hypertens. 2006;24(2):403–408. - PubMed